The addition of the film coating products from this acquisition complement Colorcon's existing wide range of high-quality, one-step, tablet film coatings for pharmaceutical solid oral dose development.
Tabcoat TC®, one of the newly acquired products, is widely recognized in the Asia/Pacific market. It is available as an organic, hydro-alcoholic, or aqueous solvent system which can be adjusted according to the needs of the customers, and the nature of the active ingredient in the formulation. The addition of this product also augments Colorcon's offering for herbal / vitamin / nutraceutical formulation options for its regional customers.
According to Jean-Claude Deneuville, President of Colorcon, Inc., "We are excited about this opportunity to expand our film coating offering. The acquisition broadens and strengthens our ability to respond to the specific needs of companies in the fast growing Asia/Pacific region. We will ensure the same high quality level of expertise, technical service, production and logistics support for these products that our customers have come to expect from Colorcon."
About Colorcon
Colorcon is a world leader in the development, supply and support of formulated products for the pharmaceutical industry. Its core businesses include film coatings, modified release technologies, functional excipients and tablet design services. Colorcon has 17 technical service laboratories globally and more than 1100 employees exclusively dedicated to its pharmaceutical customer base.
For further information, visit www.colorcon.com.
SOURCE Colorcon, Inc.
